Total Revenues in 2024 reached $492 million, representing a 427% increase over prior yearProduct Revenues in 2024 reached $273 million, ...

Shift Biosciences, a biotech company using an AI powered virtual cell to fight age-related diseases, today announced the appointments of Jill Reckless, Ph.D, as Translation Advisor and Laurence Reid, ...

NRx Pharmaceuticals (NASDAQ:NRXP – Get Free Report)‘s stock had its “buy” rating reaffirmed by D. Boral Capital in a research ...

ANI Pharmaceuticals (NASDAQ:ANIP – Get Free Report)‘s stock had its “buy” rating reissued by HC Wainwright in a research ...

SSF Plastics India Ltd has filed preliminary papers with capital markets regulator Sebi to raise Rs 550 crore through an initial public offering (IPO). The proposed IPO comprises a fresh issue of ...

Fintel reports that on March 14, 2025, Jefferies initiated coverage of ANI Pharmaceuticals (NasdaqGM:ANIP) with a Buy recommendation. Analyst Price Forecast Suggests 29.28% Upside As of March 4, 2025, ...

Fintel reports that on March 12, 2025, JP Morgan initiated coverage of ANI Pharmaceuticals (NasdaqGM:ANIP) with a Overweight recommendation. Analyst Price Forecast Suggests 27.63% Upside As of March 4 ...

Millennium Management holds 1,003K ... its portfolio allocation in ANIP by 20.47% over the last quarter. ANI Pharmaceuticals Background Information (This description is provided by the company.) ...

JJ is an employee of Robarts Clinical Trials. BGF reports grant/research support from Millennium Pharmaceuticals, Merck, Tillotts Pharma AG, AbbVie, Novartis Pharmaceuticals, Centocor, Elan/Biogen, ...